X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (36) 36
breast cancer (35) 35
female (32) 32
index medicus (31) 31
oncology (27) 27
adult (24) 24
middle aged (21) 21
mutation (19) 19
medicin och hälsovetenskap (18) 18
ovarian cancer (18) 18
aged (17) 17
cancer (17) 17
medical and health sciences (17) 17
genetic predisposition to disease (14) 14
genetic aspects (13) 13
risk factors (13) 13
breast neoplasms - genetics (12) 12
breast neoplasms - pathology (11) 11
gene mutations (11) 11
genes (9) 9
health aspects (9) 9
aged, 80 and over (8) 8
brca1 protein - genetics (8) 8
cancer och onkologi (8) 8
klinisk medicin (8) 8
obstetrics & gynecology (8) 8
ovarian neoplasms - genetics (8) 8
ovarian-cancer (8) 8
risk (8) 8
brca1 protein (7) 7
breast neoplasms - drug therapy (7) 7
cancer and oncology (7) 7
chemotherapy (7) 7
clinical medicine (7) 7
càncer d'ovari (7) 7
epidemiology (7) 7
genetics (7) 7
genetics & heredity (7) 7
medicine (7) 7
medicine & public health (7) 7
women (7) 7
brca2 protein - genetics (6) 6
breast-cancer (6) 6
carcinoma (6) 6
genotype (6) 6
germ-line mutation (6) 6
jews - genetics (6) 6
medical research (6) 6
medicinsk genetik (6) 6
medicinska och farmaceutiska grundvetenskaper (6) 6
retrospective studies (6) 6
skin and connective tissue diseases (6) 6
womens health (6) 6
antineoplastic combined chemotherapy protocols - therapeutic use (5) 5
basic medicine (5) 5
brca2 protein (5) 5
breast neoplasms - therapy (5) 5
cancer patients (5) 5
càncer de mama (5) 5
endocrine system diseases (5) 5
genes, brca1 (5) 5
genes, brca2 (5) 5
germline mutations (5) 5
heterozygote (5) 5
jews (5) 5
medical genetics (5) 5
polymorphism, single nucleotide (5) 5
pregnancy (5) 5
prognosis (5) 5
proteins (5) 5
tumors (5) 5
age (4) 4
analysis (4) 4
article (4) 4
brca (4) 4
brca1 (4) 4
brca2 (4) 4
breast (4) 4
cancer therapies (4) 4
care and treatment (4) 4
carriers (4) 4
case-control studies (4) 4
diagnosis (4) 4
family (4) 4
further section (4) 4
israel - epidemiology (4) 4
male (4) 4
neoadjuvant chemotherapy (4) 4
patients (4) 4
polymorphism, single nucleotide - genetics (4) 4
population (4) 4
research (4) 4
treatment outcome (4) 4
young adult (4) 4
age factors (3) 3
alleles (3) 3
biology (3) 3
biopsy (3) 3
brca2 mutations (3) 3
breast neoplasms (3) 3
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England Journal of Medicine, ISSN 0028-4793, 11/2016, Volume 375, Issue 18, pp. 1738 - 1748
Journal Article
The Breast, ISSN 0960-9776, 11/2017, Volume 36, pp. S19 - S20
Journal Article
The Breast, ISSN 0960-9776, 11/2017, Volume 36, pp. S19 - S20
Journal Article
by Couch, Fergus J and Wang, Xianshu and McGuffog, Lesley and Lee, Anew and Olswold, Curtis and Kuchenbaecker, Karoline B and Soucy, Penny and Fredericksen, Zachary and Barrowdale, Daniel and Dennis, Joe and Gaudet, Mia M and Dicks, Ed and Kosel, Matthew and Healey, Sue and Sinilnikova, Olga M and Lee, Adam and Bacot, François and Vincent, Daniel and Hogervorst, Frans B. L and Peock, Susan and Stoppa-Lyonnet, Dominique and Jakubowska, Anna and Radice, Paolo and Schmutzler, Rita Katharina and Domchek, Susan M and Piedmonte, Marion and Singer, Christian F and Friedman, Eitan and Thomassen, Mads and Hansen, Thomas V. O and Neuhausen, Susan L and Szabo, Csilla I and Blanco, Ignacio and Greene, Mark H and Karlan, Beth Y and Garber, Judy and Phelan, Catherine M and Weitzel, Jeffrey N and Montagna, Marco and Olah, Edith and Anulis, Irene L and Godwin, Anew K and Yannoukakos, koulis and Goldgar, David E and Caldes, Trinidad and Nevanlinna, Heli and Osorio, Ana and Terry, Mary Beth and Daly, Mary B and van Rensburg, Elizabeth J and Hamann, Ute and Ramus, Susan J and Toland, Amanda Ewart and Caligo, Maria A and Olopade, Olufunmilayo I and Tung, Nadine and Claes, Kathleen and Beattie, Mary S and Southey, Melissa C and Imyanitov, Evgeny N and Tischkowitz, Marc and Janavicius, Ramunas and John, Esther M and Kwong, Ava and Diez, Orland and Balmaña, Judith and Barkardottir, Rosa B and Arun, Banu K and Rennert, Gad and teo, Soo-Hwang and Ganz, Patricia A and Campbell, Ian and van der Hout, Annemarie H and van Deurzen, Carolien H. M and Seynaeve, Caroline and Gómez Garcia, Encarna B and van Leeuwen, Flora E and Meijers-Heijboer, Hanne E. J and Gille, Johannes J. P and Ausems, Margreet G. E. M and Blok, Marinus J and Ligtenberg, Marjolijn J. L and Rookus, Matti A and Devilee, Peter and Verhoef, Senno and van Os, Theo A. M and Wijnen, Juul T and Frost, Debra and Ellis, Steve and Fineberg, Elena and Platte, Radka and Evans, D. Gareth and Izatt, Louise and Eeles, Rosalind A and Adlard, Julian and Eccles, Diana M and Cook, Jackie and Brewer, Carole and Douglas, Fiona and Hodgson, Shirley and ... and KConFab Investigators and Ontario Canc Genetics Network and EMBRACE and GEMO Study Collaborators and CIMBA and HEBON and BCFR and SWE-BRCA and Ontario Cancer Genetics Network and kConFab Investigators and on behalf of CIMBA and Linköpings universitet and Institutionen för klinisk och experimentell medicin and Onkologi and Hälsouniversitetet
PLoS genetics, ISSN 1553-7390, 2013, Volume 9, Issue 3, p. e1003212
Journal Article
by Bojesen, Stig E and Pooley, Karen A and Johnatty, Sharon E and Beesley, Jonathan and Michailidou, Kyriaki and Tyrer, Jonathan P and Edwards, Stacey L and Pickett, Hilda A and Shen, Howard C and Smart, Chanel E and Hillman, Kristine M and Mai, Phuong L and Lawrenson, Kate and Stutz, Michael D and Lu, Yi and Karevan, Rod and Woods, Nicholas and Johnston, Rebecca L and French, Juliet D and Chen, Xiaoqing and Weischer, Maren and Nielsen, Sune F and Maranian, Melanie J and Ghoussaini, Maya and Ahmed, Shahana and Baynes, Caroline and Bolla, Manjeet K and Wang, Qin and Dennis, Joe and McGuffog, Lesley and Barrowdale, Daniel and Lee, Anew and Healey, Sue and Lush, Michael and Tessier, Daniel C and Vincent, Daniel and Bacot, Françis and Vergote, Ignace and Lambrechts, Sanina and Despierre, Evelyn and Risch, Harvey A and González-Neira, Anna and Rossing, Mary Anne and Pita, Guillermo and Doherty, Jennifer A and Alvarez, Nuria and Larson, Melissa C and Fridley, Brooke L and Schoof, Nils and Chang-Claude, Jenny and Cicek, Mine S and Peto, Julian and Kalli, Kimberly R and Broeks, Annegien and Armasu, Sebastian M and Schmidt, Marjanka K and Braaf, Linde M and Winterhoff, Boris and Nevanlinna, Heli and Konecny, Gottfried E and Lambrechts, Diether and Rogmann, Lisa and Guénel, Pascal and Teoman, Attila and Milne, Roger L and Garcia, Joaquin J and Cox, Angela and Shridhar, Vijayalakshmi and Burwinkel, Barbara and Marme, Frederik and Hein, Rebecca and Sawyer, Elinor J and Haiman, Christopher A and Wang-Gohrke, Shan and Anulis, Irene L and Moysich, Kirsten B and Hopper, John L and Odunsi, Kunle and Lindblom, Annika and Giles, Graham G and Brenner, Hermann and Simard, Jacques and Lurie, Galina and Fasching, Peter A and Carney, Michael E and Radice, Paolo and Wilkens, Lynne R and Swerdlow, Anthony and Goodman, Marc T and Brauch, Hiltrud and Garcia-Closas, Montserrat and Hillemanns, Peter and Winqvist, Robert and Dürst, Matthias and Devilee, Peter and Runnebaum, Ingo and Jakubowska, Anna and Lubinski, Jan and Mannermaa, Arto and Butzow, Ralf and ... and Gene Environm Interactimi Breast and Kathleen Cuningham Fdn Consortium and Australian Ovarian Canc Study and Epidemiological Study BRCA1 and Hereditary Breast Ovarian Canc Res and Genetic Modifiers Canc Risk BRCA1 and Australian Canc Study and Swedish Breast Canc Study SWE-BRCA and The Hereditary Breast and Ovarian Cancer Research Group Netherlands (HEBON) and Genetic Modifiers of Cancer Risk in BRCA1/2 Mutation Carriers (GEMO) and Gene Environment Interaction and Breast Cancer (GENICA) and Swedish Breast Cancer Study (SWE-BRCA) and Epidemiological study of BRCA1 & BRCA2 Mutation Carriers (EMBRACE) and Australian Ovarian Cancer Study and Australian Cancer Study and Kathleen Cuningham Foundation Consortium for Research into Familial Breast Cancer (kConFab) and Medicinska fakulteten and Umeå universitet and Institutionen för strålningsvetenskaper
Nature genetics, ISSN 1061-4036, 2013, Volume 45, Issue 4, pp. 371 - 384
Journal Article
Journal Article
Breast Cancer Research and Treatment, ISSN 0167-6806, 9/2011, Volume 129, Issue 2, pp. 557 - 563
BRCA1 and BRCA2 germline mutations substantially increase breast and ovarian cancer risk, yet penetrance is incomplete. The effects of oral contraceptives (OC)... 
Parental origin of mutation | Oncology | Breast cancer | Medicine & Public Health | OC use | BRCA1/BRCA2 germline mutations | POPULATION | SERIES | OVARIAN-CANCER | WOMEN | PENETRANCE | GERMLINE BRCA1 | MODIFIERS | ONCOLOGY | FAMILIAL BREAST | EARLY-ONSET BREAST | ASHKENAZI | Humans | Middle Aged | Breast Neoplasms - etiology | Ovarian Neoplasms - mortality | Jews - genetics | Ovarian Neoplasms - ethnology | Ovarian Neoplasms - genetics | Young Adult | DNA Mutational Analysis | Aged, 80 and over | Germ-Line Mutation | Adult | Female | Contraceptives, Oral - adverse effects | Odds Ratio | Ovarian Neoplasms - etiology | Breast Neoplasms - ethnology | Genetic Predisposition to Disease | Risk Assessment | Risk Factors | Kaplan-Meier Estimate | Logistic Models | Survival Rate | Heredity | Chi-Square Distribution | Genes, p16 | BRCA1 Protein - genetics | Phenotype | Breast Neoplasms - genetics | Israel - epidemiology | Pedigree | Breast Neoplasms - mortality | Heterozygote | Aged | Ovarian Neoplasms - chemically induced | Breast Neoplasms - chemically induced | BRCA2 Protein - genetics | Gene mutations | Genetic aspects | Oral contraceptives | Breast feeding | Health aspects | Contraceptives industry | Risk factors | Cancer | Ovarian cancer | BRCA2 protein | BRCA1 protein | Contraceptives (oral) | Menarche | Data processing | Mutation | Regression analysis | Birth | Age
Journal Article
Fertility and Sterility, ISSN 0015-0282, 2014, Volume 102, Issue 2, pp. 488 - 495.e3
Objective To evaluate the safety and efficacy of tamoxifen co-administration during conventional controlled ovarian hyperstimulation (COH) protocols for a... 
Internal Medicine | Obstetrics and Gynecology | IVF | breast cancer | fertility preservation | controlled ovarian hyperstimulation | tamoxifen | ADJUVANT CHEMOTHERAPY | STIMULATION | RANDOMIZED-TRIALS | TISSUE | CRYOPRESERVATION | PREMENOPAUSAL WOMEN | ESTROGEN-RECEPTOR | OBSTETRICS & GYNECOLOGY | IMPACT | REPRODUCTIVE BIOLOGY | YOUNG-WOMEN | AMERICAN-SOCIETY | Estradiol - blood | Prospective Studies | Humans | Middle Aged | Oocyte Retrieval | Tamoxifen - administration & dosage | Time Factors | Cryopreservation | Infertility, Female - etiology | Adult | Female | Retrospective Studies | Chemotherapy, Adjuvant | Fertility Agents, Female - administration & dosage | Gonadotropin-Releasing Hormone - agonists | Ovulation Induction - adverse effects | Tertiary Care Centers | Drug Administration Schedule | Premenopause | Risk Factors | Treatment Outcome | Fertility Preservation - methods | Gonadotropin-Releasing Hormone - antagonists & inhibitors | Biomarkers - blood | Breast Neoplasms - drug therapy | Infertility, Female - blood | Hormone Antagonists - administration & dosage | Fertility Preservation - adverse effects | Estrogen Antagonists - administration & dosage | Fertilization in Vitro | Ovulation Induction - methods | Estrogen Antagonists - adverse effects | Breast Neoplasms - blood | Tamoxifen - adverse effects | Fertility Agents, Female - adverse effects | Infertility, Female - therapy | Cancer patients | Breast cancer | Safety and security measures | Tamoxifen
Journal Article
Journal Article